Lawyer: Soldier in Afghan case took malarial drug

July 19, 2013

(AP)—The lawyer for the American soldier who killed 16 Afghan civilians says Staff Stg. Robert Bales used a controversial malarial drug linked to paranoia, hallucinations and psychosis while on a previous deployment in Iraq.

The Seattle Times reports (tinyurl.com/krppxrk ) that it's unclear whether Bales took the same drug in the days leading up to the slayings last year near a remote Army outpost in Afghanistan.

The U.S. Food and Drug Administration earlier this month released a 2012 "adverse event" notification from a pharmacist who reported that an unnamed Army taking mefloquine murdered Afghan civilians. Bales' attorney, John Henry Browne, told the Times that he has documents indicating his client took the drug while in Iraq, but said medical records for his client's time in Afghanistan are incomplete.

"We know that he was given Lariam while in Iraq," Browne said, referring to the drug's brand name. "We just don't have a complete set of medical records for that period (in Afghanistan). "He (Bales) can't help us. He just says he took 'whatever they gave me.' "

Bales pleaded guilty to the killings last month. A jury will decide in August whether the soldier is sentenced to life with or without the possibility of parole.

Browne declined to say whether he would raise Bales' use of mefloquine as a possible contributing factor to his crimes.

The lawyer said he had no indication that the pharmacist's notification was filed by anyone with direct knowledge of Bales' use of the in Afghanistan. Army officials have not commented on whether Bales took mefloquine in Afghanistan, citing confidentiality laws that protect a patient's records.

Bales, an Ohio native and father of two from Lake Tapps, Washington, slipped away from his remote southern Afghanistan outpost at Camp Belambay early on March 11, 2012, and attacked compounds in nearby villages.

Most of the victims were women and children, and some of the bodies were piled and burned. The slayings drew such angry protests that the U.S. temporarily halted combat operations in Afghanistan.

Explore further: Army: PTSD treatable; some diagnosed return to war

Related Stories

Army: PTSD treatable; some diagnosed return to war

March 23, 2012
(AP) -- It is still not known if the soldier accused of killing 17 Afghans was ever diagnosed with post-traumatic stress disorder - but even if he had been, that alone would not have prevented him from being sent back to ...

Mental disorders in 13.5 percent of Canadian Forces personnel deployed to Afghanistan

July 2, 2013
An important minority—13.5%—of Canadian Forces personnel who served in support of the Afghanistan mission in 2001–08 have been found to have a mental health disorder related to their deployment, according to a study ...

UK study says violence more likely among vets, troops

March 15, 2013
Young men who have served in the British military are about three times more likely than civilians to have committed a violent offense, researchers reported Friday in a study that explores the roots of such behavior.

UK military personnel at increased risk of violent offending

March 14, 2013
Most strikingly, the study found that the proportion of young servicemen (under 30 years old) with a conviction for violent offending was much higher than among men of a similar age in the general population (20.6% vs 6.7%).

Recommended for you

Researchers crack the smile, describing three types by muscle movement

July 27, 2017
The smile may be the most common and flexible expression, used to reveal some emotions, cover others and manage social interactions that have kept communities secure and organized for millennia.

Even babies can tell who's the boss, UW research says

July 27, 2017
The charismatic colleague, the natural leader, the life of the party - all are personal qualities that adults recognize instinctively. These socially dominant types, according to repeated studies, also tend to accomplish ...

Ketamine for depression encouraging, but questions remain around long-term use

July 27, 2017
A world-first systematic review into the safety of ketamine as a treatment for depression, published in the prestigious Lancet Psychiatry, shows the risks of long-term ketamine treatment remain unclear.

DREAMers at greater risk for mental health distress

July 27, 2017
Immigrants who came to the United States illegally as small children and who meet the requirements of the Development Relief and Education for Alien Minors Act, more commonly known as DREAMers, are at risk for mental health ...

Negativity, be gone—new online tool can retrain your brain

July 27, 2017
Anxiety and depression can have devastating effects on people's lives. In some cases, the mental disorders lead to isolation, poverty and poor physical health, things that often cascade to future generations.

Research aims to shape more precise treatments for depression in women

July 27, 2017
Among women in the United States, depression is at epidemic levels: Approximately 12 million women in the U.S. experience clinical depression each year, and more than 12 percent of women can expect to experience depression ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.